A new, very large test, shows that bare-metal stents barely work in patients with chronic chest pain who have their heart disease managed with medicine. Boston Scientific needs stent use to continue to rise…
Life does not get any easier for Pfizer (PFE). Forget generics. Now other drug firms are ganging up on them. Merck (MRK) and Schering-Plough are going to offer drug that combines their cholestoral drug…
Dendreon(DNDN-NASDAQ) is going to be one of "THE TOP ISSUES" this week. The company will have and FDA review panel on Thursday, and you should just expect that if you are an active trader…
The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s Business Daily (3/24/07) scores out of 100 (last week’s rank, change in score): 1(1)…
I have received comments on Dendreon (DNDN-NASDAQ) for this week that are both positive and negative on how well its Sipuleucel-T (Provenge) is thought of ahead of the FDA panel review this week. This…
Dendreon (DNDN-NASDAQ) is still getting plenty of trader attention this morning. It is going to post significantly higher volume than normal today as the chat rooms and message boards are filling up with more…
Shares of biotech giant Amgen (AMGN) fell another 4% last night after the company announced more negative news. The company is abandoning a clinical trial of Vectibix, its "was-promising" colon cancer treatment. An interim…
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotechnology OSIRIS THERAPEUTICS +15.40% REXAHN PHARMACEUTICL +12.90% ADVENTRX PHARMACTL +10.05% MEDICURE INC +8.91% BIONOVO INC +8.51% Diagnostic Substances RG GLBL LIFESTYLS +17.45% SYNOVICS PHARMACEUTL +11.20% EPIX PHARMACEUTICALS…
Dendreon (DNDN-NASDAQ) started making a mystery move at the end of the day, but you have to look at its calendar to see why it moved. It appears that the company has an FDA…
by H.S. AyoubBioHealth Investor.com Biotechnology OSIRIS THERAPEUTICS +12.53% EMERGENT BIOSOLUTION +9.25% ZIOPHARM ONCOLOGY IN +8.91% NANOGEN INC +8.20% NEURO-HITECH INC +6.60% Diagnostic Substances ADVANCE MAGNETIC +6.49% REMOTEMDX INC +6.25% AMER BIO MEDICA +5.45% AVALON…
On tonight’s MAD MONEY on CNBC, Jim Cramer said the action of the Defensive Stocks makes you need to watch the drug stocks in case the Fed doesn’t actually cut rates like they should. …
Did you ever think the FDA or other industry-government regulatory and advisory boards were free from a conflict of interest? If so, guess again. Today the FDA is issuing some new guidelines that are…
by H.S. AyoubBioHealth Investor.com Biotechnology GENVEC INC +11.51% REXAHN PHARMACEUTICL +10.71% 3SBIO INC +9.64% TERCICA INC +8.47% SEATTLE GENETICS I +8.14% Diagnostic Substances AVALON PHARMACEUTIC +14.80% GENELABS TECH INC +6.96% SYNOVICS PHARMACEUTL +5.04% REMOTEMDX…
The number of people with Alzheimer’s disease rises above five million, one of the questions that come up is who will care for the patients. As The Wall Street Journal points out, the baby…
Coated stents cost more than un-coated ones. Putting the drugs onto the coated stents must add expense. But, that means that coated stents make more money for Boston Scientific (BSX) and Johnson & Johnson…